ZURA
NASDAQ
US
Zura Bio Limited - Class A Ordinary shares
$6.03
▲ +$0.00
(+0.00%)
Vol 445K
4
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$340.7M
ROE
-49.5%
D/E
0.00
Beta
0.20
52W
$1–$5
Wall Street Consensus
14 analysts · Apr 20266
Strong Buy
7
Buy
1
Hold
0
Sell
0
Strong Sell
92.9%
Buy Rating
Price Chart
Similar Stocks
TECX
Tectonic Therapeutic Inc
$390.4M
KYTX
Kyverna Therapeutics Inc
$537.0M
EIKN
Eikon Therapeutics Inc
CBIO
Crescent Biopharma Inc
$164.8M
UPB
Upstream Bio Inc
$1.5B
RIGL
Rigel Pharmaceuticals Inc
P/E 6.9
$777.4M
LRMR
Larimar Therapeutics Inc
$326.1M
TRDA
Entrada Therapeutics Inc
$392.9M
VSTM
Verastem Inc
$581.5M
Earnings
Beat rate: 40.0%
Next Report
May 06, 2026
EPS Estimate: $-0.18
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | $-0.18 | — | — |
| Dec 2025 | $-0.20 | $-0.49 | $-0.29 |
| Sep 2025 | $-0.19 | $-0.21 | $-0.02 |
| Jun 2025 | $-0.19 | $-0.17 | +$0.02 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -48.1% | -41.5% | -48.1% | -48.1% | -48.1% | -49.5% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 8.40 | 8.14 | 8.40 | 8.40 | 8.40 | 5.58 |
Key Ratios
ROA (TTM)
-39.3%
P/B
1.1
EPS (TTM)
$-0.69
CF/Share
$0.03
52W High
$5.07
52W Low
$0.97
$0.97
52-Week Range
$5.07
How does ZURA compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
ZURA valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼
0%
below
peers
(12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
1.1
▼
55%
below
peers
(2.5)
vs Peers
vs Industry
Undervalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
ZURA profitability vs Biotechnology peers
ROE
-49.5%
▲
26%
above
peers
(-67.3%)
vs Peers
vs Industry
Below avg
Net margin
—
▼
0%
below
peers
(-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
-39.3%
▲
16%
above
peers
(-46.7%)
vs Peers
vs Industry
Below avg
ZURA financial health vs Biotechnology peers
D/E ratio
0.0
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
Low debt
Current ratio
5.6
▲
26%
above
peers
(4.4)
vs Peers
vs Industry
Below avg
Beta
0.2
▼
79%
below
peers
(1.0)
vs Peers
vs Industry
More volatile
ZURA fundamentals radar
ZURA
Peer median
Industry
ZURA profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
ZURA vs peers: key metrics
Latest News
No related news yet